BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37945969)

  • 21. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
    Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
    J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
    Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
    Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.
    Shen S; Jiang M; Deng W; Liu X; Xiong J; Zeng Z; Zhao H; Zeng X; Fu B
    J Gene Med; 2022 Nov; 24(11):e3418. PubMed ID: 35357059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma.
    Li J; Huang C; Zou Y; Yu J; Gui Y
    J Cell Mol Med; 2020 Jun; 24(12):6609-6621. PubMed ID: 32342645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0037866 Contributes to the Tumorigenesis of Renal Cell Carcinoma by Sequestering miR-384 to Elevate Chromobox 5 Expression.
    Shi X; Song S; Gao Y; Cui Z; Wang W; Liu M
    Kidney Blood Press Res; 2022; 47(5):329-340. PubMed ID: 35249038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of circular RNA reveals a potential miR-145-5p sponge function of circ-AFF2 and circ-ASAP1 in renal cell carcinoma.
    Ji Z; Lu R; Wu T; Chen Z; Wen Z; Li Z; Zheng X; Tang J; Chen X; Yang Y; Zheng Q
    Am J Transl Res; 2023; 15(1):82-98. PubMed ID: 36777845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
    Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
    Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis.
    Li M; Zhang M; Chen M; Xiao J; Mu X; Peng J; Fan J
    Cell Cycle; 2022 Jul; 21(13):1376-1390. PubMed ID: 35285410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma.
    Li W; Yang FQ; Sun CM; Huang JH; Zhang HM; Li X; Wang GC; Zhang N; Che JP; Zhang WT; Yan Y; Yao XD; Peng B; Zheng JH; Liu M
    Theranostics; 2020; 10(10):4395-4409. PubMed ID: 32292503
    [No Abstract]   [Full Text] [Related]  

  • 31. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55.
    Feng J; Guo Y; Li Y; Zeng J; Wang Y; Yang Y; Xie G; Feng Q
    J Exp Clin Cancer Res; 2020 Dec; 39(1):269. PubMed ID: 33256799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 34. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression.
    Chen Z; Wang Z; Chen Z; Fu F; Huang X; Huang Z
    Cell Biol Int; 2021 Dec; 45(12):2479-2489. PubMed ID: 34431162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0039569 Competes with MARCKS for miR-133b Binding Sites to Promote the Progression of Renal Cell Carcinoma.
    Zhao P; Zhang J
    Nephron; 2022; 146(4):404-417. PubMed ID: 35086110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR-140-5p/LMNB1 axis.
    Fu W; Wang X; Xiang J; Chen S; Xia R; Xie F; Chi B; Qin F; Li Z; Mou L; Xie C; Wang H
    Cancer Med; 2023 May; 12(10):11651-11671. PubMed ID: 37041721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.